22-21015224-C-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005446.5(P2RX6):c.50C>G(p.Thr17Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T17M) has been classified as Uncertain significance.
Frequency
Consequence
NM_005446.5 missense
Scores
Clinical Significance
Conservation
Publications
- myopathyInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005446.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| P2RX6 | TSL:1 MANE Select | c.50C>G | p.Thr17Arg | missense | Exon 1 of 12 | ENSP00000416193.2 | O15547-1 | ||
| P2RX6 | TSL:1 | c.50C>G | p.Thr17Arg | missense | Exon 1 of 12 | ENSP00000385309.1 | O15547-2 | ||
| P2RX6 | TSL:1 | n.35C>G | non_coding_transcript_exon | Exon 1 of 11 | ENSP00000407920.1 | H7C2V4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000559 AC: 1AN: 178872 AF XY: 0.0000101 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 7.23e-7 AC: 1AN: 1382358Hom.: 0 Cov.: 32 AF XY: 0.00000146 AC XY: 1AN XY: 686096 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at